Results 101 to 110 of about 41,151 (199)

Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment. [PDF]

, 1995
John Harrison, Leslie Henderson, Christopher Kennard   +2 more
openalex   +1 more source

Randomised, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of antibiotic faecal microbiota transplantation in patients with Parkinson's disease (FLORA-PD): a study protocol. [PDF]

BMJ Open
Takeshige-Amano H, Igami E, Okuzumi A, Kamo R, Iseki M, Tsuyama K, Wakamori R, Okada H, Taniguchi D, Ueno SI, Oji Y, Ishikawa KI, Nishikawa N, Orikasa M, Odakura R, Koma M, Maruyama T, Nomura K, Ishikawa D, Shibuya T, Nagahara A, Teramoto H, Yanagisawa N, Hatano T, Hattori N.   +24 more
europepmc   +1 more source

Should levodopa therapy for parkinson's disease be started early or late? clinical course of the major tetrad in 122 parkinsonian patients treated with levodopa over 14 years.

, 1989
T Indo, Akira Takahashi
openalex   +2 more sources

Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa. [PDF]

Eur J Neurol
Morgante F, Artusi CA, Ricciardi L, Sarchioto M, Montanaro E, Edwards MJ, Lopiano L, Zibetti M.   +7 more
europepmc   +1 more source

Risperidone in levodopa induced dyskinesiae [PDF]

, 1998
G. Meco, Fabrizio Ecca, Andrea Alessandri, N. Vanacore, Vincenzo Bonifati   +4 more
openalex   +1 more source

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson [PDF]

, 1995
Maria Sheila Guimarães Rocha, Luís Eduardo Coelho Andrade, Henrique Ballalai Ferraz, Vanderci Borges   +3 more
openalex   +1 more source

Acute overdosage and intoxication with carbidopa/levodopa can be detected in the subacute stage by measurement of 3-o-methyldopa [PDF]

, 1999
H. J. Stuerenburg, Benedikt Schoser
openalex   +1 more source

Correction: Opportunities for and Challenges of Pulmonary Drug Delivery in the Management of Acute Exacerbations of CNS Disorders. [PDF]

CNS Drugs
Detyniecki K, Strzelczyk A, Roebling R, Laloyaux C, Chanteux H, Cloyd JC.   +5 more
europepmc   +1 more source

Parkinson disease treatments on national essential medicines lists, African Region. [PDF]

Bull World Health Organ
Fothergill-Misbah N, Cataldi R, Stothard M, Chowdhary N, Okubadejo N, Cappello B, Walker R, Dua T.   +7 more
europepmc   +1 more source

Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation [PDF]

, 2000
B. Paul Bejjani
openalex   +1 more source